Provider Regulation, B.C. Reg. 222/2014
Section 22
Suspension of payments
Cite as Provider Regulation, B.C. Reg. 222/2014, s. 22 · last amended April 1, 2026 · read from BC Laws on November 17, 2026
The text
(1) For the purposes of section 45 (1) (a) (ii) [suspension of payments] of the Act, the prescribed offences are as follows:
(a) sections 362, 366, 380, 388, 389, 392, 397, 402, 402.2, 403 and 408 [fraud] of the Criminal Code;
(b) section 5 [trafficking] of the Controlled Drugs and Substances Act (Canada);
(c) section 46 of the Controlled Drugs and Substances Act (Canada), as it relates to a contravention of any provision of
(i) Part 2 [permitted activities and general obligations of pharmacists] of the Benzodiazepines and Other Targeted Substances Regulations (Canada), SOR/2000-217, or
(ii) sections 30 to 45 of the Narcotic Control Regulations (Canada), C.R.C., c. 1041.
(2) For the purposes of section 45 (1) (b) of the Act, the prescribed circumstances are as follows:
(a) if the provider is a corporation and an officer or a director of the provider has been convicted of an offence referred to in subsection (1) of this section;
(b) if a provider becomes ineligible to be enrolled as a provider, except in the circumstances described in section 2 (2) (a) or (e) (i) or (ii) [when not eligible for enrolment];
(c) in the case of a pharmacy provider enrolled in the opioid agonist treatment provider sub-class, if the pharmacy provider's site is no longer served by pharmacists who are appropriately qualified as described in section 3 (4) [enrolment of pharmacy providers];
(d) in the case of a device provider enrolled in a sub-class referred to in section 4 (3) [enrolment of device providers], if the device provider's site is no longer served by a person who is appropriately qualified as described by that section to provide the type of benefits relevant to the sub-class.
(3) If a provider is enrolled in more than one sub-class, suspension of payments in the circumstances described in
(a) subsection (2) (c) may only be in respect of claims related to the provision of opioid agonist treatment services, and
(b) subsection (2) (d) may only be in respect of claims related to the provision of benefits relevant to the sub-class for which the device provider's site is no longer served by an appropriately qualified person.
Read the Provider Regulation on BC Laws ↗
Made under Pharmaceutical Services Act, SBC 2012, c. 22.